Published December 2, 2024
| Version v1
Project deliverable
Open
NODES_Inndiana_D14_RM4_Biphenyl Amides as Dual-Targeting SOCE/DHODH Inhibitors
Authors/Creators
-
1.
Università degli Studi del Piemonte Orientale "Amedeo Avogadro"
Contributors
Other:
Description
The patent application titled “Biphenyl Amides as Dual-Targeting SOCE/DHODH Inhibitors” (No. 102024000024384) describes novel biphenyl amides that can simultaneously modulate Store-Operated Calcium Entry (SOCE) and human dihydroorotate dehydrogenase (hDHODH) for the treatment of autoimmune, inflammatory, and chronic degenerative diseases, as well as neurodegenerative and multisystem inflammatory diseases associated with SOCE overactivation and DHODH pathway alterations.
Files
Deliverable_D14_INNDIANA_RM4_Ottobre2024_Patent application on dual-targeting SOCE-DHODH inhibitors.pdf
Files
(3.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f7e0678288e199c5788ebf083f183539
|
3.0 MB | Preview Download |